Intradermal immunotherapy: A promising solution to cure prostate cancer?
Our latest white paper explores the potential of immunotherapy and intradermal delivery to improve treatment strategies for prostate cancer.
- How cancer vaccines and mRNA technologies are advancing prostate cancer immunotherapy
- Why intradermal delivery can enhance immune responses
- The challenges of conventional Mantoux technique
- How VAX-ID enables standardized, accurate, and reliable intradermal delivery of vaccines